


Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of Talecris Biotherapeutics Holdings Corp.
BENSALEM, Pa.--([ BUSINESS WIRE ])--Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Talecris Biotherapeutics Holdings Corp. (aTalecrisa or the aCompanya) (NASDAQ:TLCR) related to the Companya™s agreement to be acquired by Grifols, S.A. (aGrifolsa). The proposed cash-and-stock transaction is valued at approximately $3.4 billion.
Under the terms of the definitive agreement entered into by the parties, Grifols will acquire all of the common stock of Talecris for $19.00 in cash and 0.641 newly issued non-voting Grifols' shares for each Talecris share. The deal values each Talecris share at approximately $26.16, based on the closing price of Grifols' ordinary shares as of June 4th, 2010 and prevailing Euro-Dollar exchange rates. The proposed transaction is expected to be completed in the second half of 2010. In connection with the offer, the leading shareholders of Grifols have agreed to vote their shares in favor of the transaction, and an affiliate of Cerberus Capital Management, L.P., which owns approximately 49% of the outstanding Talecris common stock, has entered a similar agreement. The investigation concerns possible breaches of fiduciary duty and other violations of law related to approval of the transaction by Talecrisa™ board of directors.
If you own shares of Talecris, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to [ howardsmith@howardsmithlaw.com ], or visit our website at [ http://www.howardsmithlaw.com ].